Davide Bonazzi
Illustrator
From this contributor
Company on brink takes psilocybin to trial for fragile X syndrome
The phase 2A trial has its detractors despite positive animal results and is being sponsored by a company that is struggling financially.
Company on brink takes psilocybin to trial for fragile X syndrome
Explore more from The Transmitter
Still no proof for facilitated spelling methods
A systematic review into whether the “rapid prompting method” or “spelling to communicate” can help autistic people express themselves comes up empty yet again.
Still no proof for facilitated spelling methods
A systematic review into whether the “rapid prompting method” or “spelling to communicate” can help autistic people express themselves comes up empty yet again.
Oregon primate center scientists fight proposed sanctuary transition
A group of employees have launched a series of campaigns to advocate for their work and argue against the center’s potential transition to an animal sanctuary.
Oregon primate center scientists fight proposed sanctuary transition
A group of employees have launched a series of campaigns to advocate for their work and argue against the center’s potential transition to an animal sanctuary.
When autistic kids grow up
An autistic researcher’s paper called attention to a huge disparity in autism funding research between children and adults. It nearly derailed her life.
When autistic kids grow up
An autistic researcher’s paper called attention to a huge disparity in autism funding research between children and adults. It nearly derailed her life.